Literature DB >> 11846206

Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma.

N Tsuchiya1, K Sato, T Akao, H Kakinuma, R Sasaki, N Shimoda, S Satoh, T Habuchi, O Ogawa, T Kato.   

Abstract

Vascular endothelial growth factor (VEGF)-related factors are believed to regulate angiogenesis, an essential event in the growth of solid tumors. In this study, we investigated the expression of VEGF-related factor genes (VEGF, VEGF-B, and VEGF-C) and their receptor genes (VEGFR-1 and VEGFR-2) in renal cell carcinoma (RCC). There were significant differences in the expression level of VEGF, VEGFR-1 and VEGFR-2 between RCC and the corresponding normal renal tissue. The expression level of VEGF in the tumor tissue significantly correlated with those of VEGFR-1 and VEGFR-2. Expression levels VEGF-B and VEGF-C genes were not significantly different between RCC and normal renal tissue. A moderate to high protein expression for VEGF, VEGFR-1, and VEGFR-2 was observed in both the tumor cells and the endothelial cells, whereas the protein expression was low for VEGF-B and VEGF-C. The present results suggested that VEGF and its receptors VEGFR-1 and VEGFR-2 cooperates to play a crucial role in the angiogenesis of RCC, while VEGF-B and VEGFR-C may not. Furthermore, since VEGFR-1 and VEGFR-2 proteins were expressed in the tumor cells as well as in the endothelial cells, these receptors may also be responsible for the progression of RCC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11846206     DOI: 10.1620/tjem.195.101

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  9 in total

1.  Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors.

Authors:  Matilde Lombardero; Sergio Vidal; Robert Hurta; Alba Román; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

2.  Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas.

Authors:  Bernard Paule; Laurence Bastien; Emmanuelle Deslandes; Olivier Cussenot; Marie-Pierre Podgorniak; Yves Allory; Benyoussef Naïmi; Raphael Porcher; Alexandre de La Taille; Suzanne Menashi; Fabien Calvo; Samia Mourah
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

3.  Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.

Authors:  Wesam M Osman; Nermeen S Youssef
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 4.  Current status and perspective of antiangiogenic therapy for cancer: urinary cancer.

Authors:  Shigeru Kanda; Yasuyoshi Miyata; Hiroshi Kanetake
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.850

5.  A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma.

Authors:  Simon Chowdhury; Jeffery R Infante; Robert Hawkins; Martin H Voss; Rodolfo Perini; Tobias Arkenau; Mark Voskoboynik; Paola Aimone; Isabelle Naeije; Albert Reising; David F McDermott
Journal:  Clin Genitourin Cancer       Date:  2021-04-20       Impact factor: 3.121

6.  Impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma.

Authors:  Shin Kumagai; Kei Ishibashi; Masao Kataoka; Toshiki Oguro; Yuichirou Kiko; Tomohiko Yanagida; Ken Aikawa; Yoshiyuki Kojima
Journal:  Cancer Sci       Date:  2016-11       Impact factor: 6.716

7.  Expression of growth factors and their receptors in the primary renal cell carcinoma: new data and review.

Authors:  Maria Volkova; Ilya Tsimafeyeu; Anna Olshanskaya; Yulia Khochenkova; Elyso Solomko; Saida Ashuba; Dmitry Khochenkov; Vsevolod Matveev
Journal:  Cent European J Urol       Date:  2020-12-09

Review 8.  Progress of molecular targeted therapies for advanced renal cell carcinoma.

Authors:  Alessandro Conti; Matteo Santoni; Consuelo Amantini; Luciano Burattini; Rossana Berardi; Giorgio Santoni; Stefano Cascinu; Giovanni Muzzonigro
Journal:  Biomed Res Int       Date:  2013-09-04       Impact factor: 3.411

9.  Key pathways and genes controlling the development and progression of clear cell renal cell carcinoma (ccRCC) based on gene set enrichment analysis.

Authors:  Haipeng Huang; Yanyan Tang; Wenwu He; Qi Huang; Jianing Zhong; Zhanbin Yang
Journal:  Int Urol Nephrol       Date:  2013-08-14       Impact factor: 2.370

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.